Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
The healthcare sector is constantly changing, and many practices have been modified to become more efficient: So how can technology help with advancing surgeries?
A Diabetes UK survey of more than 2,000 adults with diabetes from across the UK found that 15% have needed specialist emotional support to help them cope with the demands of living with the condition within the last year.
New research from Diabetes UK has found that seven out of ten people feel overwhelmed by the demands of living with diabetes, which significantly affects their mental and physical health.
Patients who have been diagnosed with diabetes are at a lower risk of early death if they have a doctor who they describe as showing empathy towards them, a new study from the University of Cambridge has found.
A new tool designed to help healthcare professionals boost diabetes referrals to structured education courses is being announced by Diabetes UK and Kent and Medway STP.
Jeremy Hunt commits £70 million funding over three and a half years for the Better Health Programme, a range of health initiatives that could improve the lives of up to 150 million people across 8 emerging economies.
Diabetes UK and JDRF have announced their continued commitment to revolutionising Type 1 diabetes treatment, by awarding £490,000 to fund the next generation of immunotherapy research.
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.
University of Oxford and Manchester researchers found that children monitored regularly for height and weight from an early age will be less likely to experience child obesity.
Peter Robins, from Metabolic Health Solutions (MHS), describes how a new clinical management tool can help individualise treatment of obesity and Type 2 diabetes.
